Eri Hagiwara to Aged
This is a "connection" page, showing publications Eri Hagiwara has written about Aged.
Connection Strength
0.053
-
Clinical characteristics and early outcomes of patients newly diagnosed with pulmonary Mycobacterium avium complex disease. Respir Investig. 2019 Jan; 57(1):54-59.
Score: 0.014
-
Clinical characteristics of Japanese patients with moderate to severe COVID-19. J Infect Chemother. 2021 Jun; 27(6):895-901.
Score: 0.004
-
Pulmonary vascular enlargement and lesion extent on computed tomography are correlated with COVID-19 disease severity. Jpn J Radiol. 2021 May; 39(5):451-458.
Score: 0.004
-
Pneumothorax in a COVID-19 Pneumonia Patient without Underlying Risk Factors. Intern Med. 2020 Nov 15; 59(22):2921-2925.
Score: 0.004
-
Ultra-high-resolution computed tomography can demonstrate alveolar collapse in novel coronavirus (COVID-19) pneumonia. Jpn J Radiol. 2020 May; 38(5):394-398.
Score: 0.004
-
Radiological images of interstitial pneumonia in mixed connective tissue disease compared with scleroderma and polymyositis/dermatomyositis. Eur J Radiol. 2018 Oct; 107:26-32.
Score: 0.003
-
Predictive Factors for the Long-Term Deterioration of Pulmonary Function in Interstitial Lung Disease Associated with Anti-Aminoacyl-tRNA Synthetase Antibodies. Respiration. 2018; 96(3):210-221.
Score: 0.003
-
Prognostic factors and disease behaviour of pathologically proven fibrotic non-specific interstitial pneumonia. Respirology. 2018 11; 23(11):1032-1040.
Score: 0.003
-
Unilateral Upper Lung Field Pulmonary Fibrosis Radiologically Consistent with Pleuroparenchymal Fibroelastosis after Thoracotomy: A New Disease Entity Related to Thoracotomy. Respiration. 2017; 94(5):431-441.
Score: 0.003
-
Pathologically Proven Spontaneous Remission of IgG4-related Retroperitoneal Fibrosis. Intern Med. 2017; 56(14):1867-1871.
Score: 0.003
-
Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy. BMC Pulm Med. 2016 12 01; 16(1):168.
Score: 0.003
-
[[COMPLIANCE RATE OF STANDARD TREATMENT REGIMEN AND OPTIMAL DOSE OF ANTI-TUBERCULOSIS DRUGS IN LATE ELDERLY PATIENTS WITH PULMONARY TUBERCULOSIS].] Kekkaku. 2016 May; 91(5):495-502.
Score: 0.003